Podcasts about google play store

If you've ever felt overwhelmed trying to piece together how blood pressure, fluid balance, and heart failure meds all connect, this episode is for you. In this lesson, we're diving into the RAAS pathway, also known as the renin-angiotensin-aldosterone system, and how this one system plays a major role in so many things you'll encounter in nursing school and beyond. You'll learn how RAAS helps regulate systemic vascular resistance and fluid volume, which ultimately impact cardiac output and blood pressure. I'll walk you through the three main components—renin, angiotensin, and aldosterone—and show you exactly how they interact to keep the body in balance. We'll also cover the medications that disrupt this pathway, including ACE inhibitors, ARBs, and aldosterone receptor blockers. These are foundational drugs used to treat hypertension and heart failure, and understanding the pathway gives you a deeper understanding of why and how they work. Plus, we touch on the role of pharmacologic angiotensin II in hypotension and septic shock. This episode highlights how mastering one system—just one!—can give you a big-picture view of multiple conditions and treatments. It's a perfect example of what I teach in my free class, How to Thrive in Nursing School Without It Taking Over Your Life. And if you're ready to keep building that strong foundation, I'll also tell you how to join me inside Crucial Concepts Bootcamp. Ready to make the RAAS system finally click? Let's do it! ___________________ Full Transcript - Read the article and view references FREE CLASS - If all you've heard are nursing school horror stories, then you need this class! Join me in this on-demand session where I dispel all those nursing school myths and show you that YES...you can thrive in nursing school without it taking over your life! Crucial Concepts Bootcamp - Start nursing school ahead of the game, or reset after a difficult first semester with my nursing school prep course, Crucial Concepts Bootcamp. Learn key foundation concepts, organization and time management, dosage calculations, and so much more. Straight A Nursing App - Study on-the-go with the Straight A Nursing app! Review more than 5,000 flashcards covering a wide range of subjects including Fundamentals, Pediatrics, Med Surg, Mental Health, Maternal Newborn, and more! Available for free in the Apple App Store and Google Play Store. Pharmacology Success Pack - Want to get a head start on pharmacology? Download the FREE Pharmacology Success Pack.  Nursing School Thrive Guide - Get the book that many nursing students consider the ultimate survival guide for nursing school! Available in paperback, Kindle and audio formats.

The road to the MLS Cup has been surprisingly navigable. However, it's time to swerve right and exit the MLS highway for a pit stop in the Leagues Cup. Last season, FC Cincinnati got further into the knockout round than the season before. As much as that momentum is positive, this reiteration of the Leagues Cup has a completely different format. To get tho the smaller knockout rounds, the Orange & Blue have to go through three Liga MX squads and hope they can do so without many hiccups. So what can we expect from C.F. Monterrey, FC Juarez, and Chivas Guadalajara? We invite Jaime from Cantina MX to give us the lowdown on Chivas and Eddie from Rayados90 to reintroduce us to the Vazquez-less version of Monterrey. Juarez? Well, we can at least try to narrow down what MLS team they would be. Can this new format please everyone? Are Columbus or Inter Miami able to dominate the competition again? Does Geoff sincerely think Cruz Azul could win it all?? Tune in and trade threads with us! #MLS #FCCincinnati #soccer Become a Patron! Subscribe to Cincinnati Soccer Talk Don't forget you can now download and subscribe to Cincinnati Soccer Talk on iTunes today! The podcast can also be found on Stitcher Smart Radio now. We're also available in the Google Play Store and NOW ON SPOTIFY! As always we'd love your feedback about our podcast! You can email the show at feedback@cincinnatisoccertalk.com. We'd love for you to join us on our Facebook page as well! Like us at Facebook.com/CincinnatiSoccerTalk.

What happens when a tech-savvy Bigfoot researcher builds a live surveillance network in the most active Sasquatch hotspots across North America? In this chilling episode, we reconnect with Logan Schoessow — creator of the Bigfoot Livestream app — for a stunning update on what he's captured since his system went live. From an undisclosed location near Pennsylvania's Allegheny Forest, Logan shares footage of a mysterious nine-foot figure caught up-close on infrared, strange heat signatures, jaw-dropping vocalizations, and a scream that shook him to his core. We also explore bizarre phenomena from Radium, British Columbia, including missing apples, gifts from unseen hands, and trailer-shaking encounters. This is more than just tech — it's a war for proof. Whether you believe or not, something is watching... and now, it's being watched back.You'll hear about AI that hunts for Sasquatch, the screams that chilled a veteran researcher, and the property so haunted by creatures that the last owners left dishes in the sink and fled in the night.Resources:Search "Bigfoot Livestream App" on the Apple App Store and the Google Play Store.Referenced video - https://www.tiktok.com/@bigfoot.live.stre/video/7518918508093148447

About 50% of your new patients will not return. Why does that happen, and what can you do about it? In this episode, Kirk Behrendt brings in Brad James, director of SMB sales at Kleer and Membersy, to explain the true problem you have in your practice. You don't have a new patient problem — you have a patient loyalty problem! To learn what's keeping new patients away and how to create loyalty in your practice, listen to Episode 923 of The Best Practices Show!Learn More About Brad:Follow Kleer and Membersy on Instagram: https://www.instagram.com/kleerandmembersyLearn more about Kleer and Membersy: https://www.kleer.comMore Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 923: https://www.youtube.com/@actdental/videosWatch Episode 904 with Jeff Janssen: https://www.youtube.com/watch?v=hyBwnKvavDcRead The Membership Economy by Robbie Kellman Baxter: https://robbiekellmanbaxter.com/the-membership-economyMain Takeaways:Membership patients, on average, spend 66% more.Cash-paying patients don't come in as often as you think.Study your practice data to avoid making knee-jerk decisions.Offering membership plans builds loyalty by providing affordability.Evaluate your team before trying to manage membership plans in-house.Focus on creating loyalty across your practice, not just marketing to new patients.Uninsured patients are least likely to return, spend money, and listen to suggestions.Snippets:0:00 Introduction.1:57 Brad's background.4:28 Lacking visibility of practice data and why it's a problem.8:50 Consequences of not knowing your numbers.11:43 New patients aren't always the...

Host Bart Zandbergen welcomed the CEO of Stark Health into the studio, Todd Vande Hei, to discuss the journey to peak health. Stark exists to change the future of health and fitness in the communities they serve. For the last 15 years, Todd has been on a journey to discover what it means to be in a state of peak health. After suffering from a series of seizures and being diagnosed with high blood pressure and atrial fibrillation in his early 30's, Todd decided it was time to make a change. Those changes fell into one of four categories: lifestyle, exercise, nutrition, and stress management. But the biggest thing Todd learned through it all? Health is a skill. You're not born with it, like some would like you to believe, and it isn't acquired by simply buying another product or starting that new diet. Health is something you can create for yourself, and over time it is possible to attain peak health. Listen to this latest episode that analyzed health as the ultimate wealth. Key topics discussed in this episode include: - Brain health and the aging process - The truth about the role that genetics play in overall health and fitness - How to develop health as a skill - The road to peak health Learn more about Stark Health by visiting: https://www.stark.health/ *** The Zandbergen Report, where wealth strategies and investment wisdom collide, is led by host Bart Zandbergen. The show is also available on Apple Podcasts, Google Play Store, Podbean and Spotify. Interested in being a guest on The Zandbergen Report? Email podcast@bartzandbergen.com. Learn more about Bart by visiting www.BartZandbergen.com *** NO OFFER OR SOLICITATION: The contents of this podcast episode: (i) do not constitute an offer of securities or a solicitation of an offer to buy securities, and (ii) may not be relied upon in making an investment decision related to any investment offering Axxcess Wealth Management, LLC, an SEC Registered Investment Advisor. Axxcess does not warrant the accuracy or completeness of the information contained herein. Opinions are our current opinions and are subject to change without notice. Prices, quotes, rates are subject to change without notice. Generally, investments are NOT FDIC INSURED, NOT BANK GUARANTEED and MAY LOSE VALUE.

The US Gov is Venmo requesting us, What you can and cannot cremate,and what the fuck is a Labubu?Listen to⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ WSRR Radio⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Live wherever you go: Download the NEW WSRR RADIO APP available now on The Apple app and Google Play Store!Theme Music by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Daze⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ To support the show, be sure to pick up some sweet ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠WSRR Merch⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ from the shop!

You can't recapture 100% of your cancellations — but you can get 80% or more! In this episode, Kirk Behrendt brings back Miranda Beeson, ACT's director of education, to break down recaptured percentage, how to track it, and ways to create a strong system to increase reappointment. To learn the secrets for actively rescheduling patients, listen to Episode 922 of The Best Practices Show!Learn More About Miranda:Send Miranda an email: miranda@actdental.com Follow Miranda on ACT's Instagram: https://www.instagram.com/actdentalSend Courtney an email to learn more about ACT: courtney@actdental.com More Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 922: https://www.youtube.com/@actdental/videosJoin ACT's BPA to get the Ideal Day Scheduling Guide: https://join.actdental.com/users/sign_in?post_login_redirect=https%3A%2F%2Fjoin.actdental.com%2Fc%2Fpractice-coaching-tools%2Fcolor-coding-block-scheduling-and-ideal-day-scheduling#emailMain Takeaways:Aim to recapture 80% or more of your cancellations.Create a script to help your team reappoint cancellations on the spot.Track cancellations in real time and follow up with patients on the same day.Strengthen your verbal skills. Don't just tell patients to, “Call us when you're ready.”Build an active follow-up system. Contact patients within a day or two of a cancellation.Snippets:0:00 Introduction.1:48 Recaptured percentage, explained.4:40 How this percentage impacts your practice.6:51 What it looks like when recaptured percentage is high.8:47...

The growth of e-commerce continues at speed and keeping up with the demand is a challenge for any business. Companies that adapt best to the changing demands can reap the benefits like cost-savings and efficiency gains which lead to bigger and better growth. Smart load planning is a tool that warehouses can leverage to address the changing needs of e-commerce. Lori Boyer, head of Content Marketing for Easypost, shares some of her insights into how smart load planning can could revolutionize warehouse operations. FOR MORE INFORMATION: https://www.easypost.com/ WANT TO RESPOND TO THIS EPISODE? Call our Dialog Line: 888-878-3247 DOWNLOAD THE NEW INBOUND LOGISTICS APP featuring the updated and expanded Logistics Planner! Available on iTunes and the Google Play Store: bit.ly/ILMagApp  bit.ly/ILMagAppGoogle Are you a #logistics Thought Leader that would like to be featured on the Inbound Logistics Podcast?  Connect with me on X:  @ILMagPodcast Email me: podcast@inboundlogistics.com   Connect with Inbound Logistics Magazine on LinkedIn: https://www.linkedin.com/company/inbound-logistics Follow us on X: www.twitter.com/ILMagazine Like us on Facebook: www.facebook.com/InboundLogistics Catch our latest videos on YouTube: www.youtube.com/inboundlogistics   Visit us at www.inboundlogistics.com

In diesem ehrlichen und tiefgründigen Gespräch mit Jakob Drachenberg sprechen wir über das Vaterwerden, Stressbewältigung und den Weg zurück zur Selbstwirksamkeit. Jakob ist Psychologe, ehemaliger Leistungssportler und einer der bekanntesten Stress-Coaches im deutschsprachigen Raum. Nachdem er vor anderthalb Jahren Vater geworden ist, hat sich nicht nur sein Alltag, sondern auch seine Sicht auf Stress und Achtsamkeit grundlegend verändert.Wir sprechen über überfordernde Momente im Familienalltag, smarte Routinen für mehr Selbstfürsorge, die Herausforderung digitaler Ablenkung durch Smartphones und die Rückkehr zur eigenen Identität als Mann und Partner. Jakob teilt persönliche Erfahrungen, wie ihn das Vatersein geerdet, aber auch verwundbarer gemacht hat – und warum Selbstmitgefühl und Individualität zentrale Schlüssel für Zufriedenheit sind.Ein inspirierender Austausch über Liebe, Elternschaft, Stress, Routinen und das Loslassen von Perfektion – und warum 1 größer ist als 0.Freut ihr euch auf weitere spannende Inhalte? Abonniert "TONKA & PHIL", bewertet uns mit 5 Sternen auf eurer Lieblingsplattform und werdet Teil unserer Community.Mehr von Jakob Drachenberg:

Being rooted in truth is a by-product of trusting God. But trust comes from understanding the character of God because once you understand who God is you can stand firmly in His Word.--To hear more messages from The Image Church, subscribe to our podcast or YouTube channel. Also follow us on social media (Facebook and Instagram) or download our Image Church app in the App Store and Google Play Store to learn more about us and stay up to date.

(Bonus episode! Relive the live RSL episode of Jersey Swap in audio form.) With their biggest win in the past, FC Cincinnati focus again on the present with a suddenly-mammoth three-point challenge at Real Salt Lake Saturday. The hunter now becomes the hunted, as RSL have gone five matches unbeaten. Another change of pace—Mr. “No Days Off” took PTO this week, so Jason Ashcraft steps in for a special Jersey Swap with Scott Omer from Designated Pundits. While the primary focus will be on Diego Luna after his USMNT breakout, can the Orange & Blue return to their away form without any letdowns? Tune in and trade threads with us! #MLS #FCCincinnati #soccer Become a Patron! Subscribe to Cincinnati Soccer Talk Don't forget you can now download and subscribe to Cincinnati Soccer Talk on iTunes today! The podcast can also be found on Stitcher Smart Radio now. We're also available in the Google Play Store and NOW ON SPOTIFY! As always we'd love your feedback about our podcast! You can email the show at feedback@cincinnatisoccertalk.com. We'd love for you to join us on our Facebook page as well! Like us at Facebook.com/CincinnatiSoccerTalk.

On paper, FC Cincinnati fans may have approached this next game with some confidence. After all, keeping Lionel Messi off the scoring sheet is no small feat. Despite losing Kevin Denkey for a prolonged spell, the Orange & Blue rode Evander's brace to silence the Herons 3-0 at TQL Stadium. However, the confidence this weekend could be harder to measure. The news could focus on Evander and Messi again testing each other's MVP chances. However, Messi's absence from the All-Star Game on Wednesday has ruffled feathers in the Winged Lions' fans. That should lead to a suspension if history dictates anything, but can we honestly expect the G.O.A.T. to miss another match against Cincinnati? That possibility still exists, so we ask Alex from Bleacher Report and The Heron's Nest about such a threat. Did Pat Noonan play his cards correctly last time? Can the Orange & Blue pull another fast one against South Beach's Super Squad? What could Javier Mascherano drum up to resume Miami's defense of the Supporters' Shield? Tune in and trade threads with us! #MLS #FCCincinnati #soccer Become a Patron! Subscribe to Cincinnati Soccer Talk Don't forget you can now download and subscribe to Cincinnati Soccer Talk on iTunes today! The podcast can also be found on Stitcher Smart Radio now. We're also available in the Google Play Store and NOW ON SPOTIFY! As always we'd love your feedback about our podcast! You can email the show at feedback@cincinnatisoccertalk.com. We'd love for you to join us on our Facebook page as well! Like us at Facebook.com/CincinnatiSoccerTalk.

Hygiene is more than just preventative care. It's a way to tether patients to your practice! In this episode, Miranda Beeson, ACT's director of education, brings in four amazing ACT team members to share some of their best practices and insights for building value through hygiene. Hygienists are more than just “mouth janitors”! To learn of all the ways they provide value for your practice, listen to Episode 921 of The Best Practices Show!Learn More About the ACT Team:Send Ariel an email: ariel@actdental.com Send Angela an email: angela@actdental.com Send Miranda an email: miranda@actdental.com Send Courtney an email: courtney@actdental.com Send Christina an email: christina@actdental.com Follow the Team on ACT's Instagram: https://www.instagram.com/actdentalMore Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 921: https://www.youtube.com/@actdental/videosMain Takeaways:Hygiene is how you keep patients tethered to your practice.Be aligned on what your optimal standard of care is for patients.Always schedule the patient's next appointment before they leave.Don't underestimate the influence hygiene can have on practice growth.Put a consistent follow-up plan in place to reintroduce unscheduled patients.Use value building language to communicate why their next appointment matters.Have documented systems that support your philosophy, initiatives, and follow-ups.When doctors and hygienists work together, both the patients and the practice...

This week, join Marianna as she sits down with John Faragon to talk all about a new injectable option for PrEP that has recently been approved. Find out what it is, who it's for, and how this can affect your work as an HIV care provider. Article mentioned: https://jamanetwork.com/journals/jama/fullarticle/2827545--Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=PCS6722)--Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes. --Check out our free online courses: www.necaaetc.org/rise-courses--Download our HIV mobile apps:Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=USApple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

Welcome to church! Join us for church every Sunday at 9AM and 5PM. --------------------------------------------------------- Are you new to Father's House Church? Follow the link and fill out the form to connect with us: https://bit.ly/3nU5j30 Would you like us to pray with you? Fill out the following form: https://bit.ly/3sYGRkQ Or call us on 086 100 1350. Would you like to join or start a Group? Let us know by filling in the following form: https://bit.ly/groups_ Partner financially with us: https://www.fathershousesa.org/giving/ Listen to our podcast: https://soundcloud.com/fathers-house-sa Connect with us on all our social media platforms @fathershousesa Visit our website at www.fathershousesa.org Download Church Centre Available on both App Store (iOS) and Google Play Store: http://onelink.to/d8qk5rWelcome to church! Join us for church every Sunday at 9AM and 5PM. --------------------------------------------------------- Are you new to Father's House Church? Follow the link and fill out the form to connect with us: https://bit.ly/3nU5j30 Would you like us to pray with you? Fill out the following form: https://bit.ly/3sYGRkQ Or call us on 086 100 1350. Would you like to join or start a Group? Let us know by filling in the following form: https://bit.ly/groups_ Partner financially with us: https://www.fathershousesa.org/giving/ Listen to our podcast: https://soundcloud.com/fathers-house-sa Connect with us on all our social media platforms @fathershousesa Visit our website at www.fathershousesa.org Download Church Centre Available on both App Store (iOS) and Google Play Store: http://onelink.to/d8qk5r

Welcome to church! Join us for church every Sunday at 9AM and 5PM. --------------------------------------------------------- Are you new to Father's House Church? Follow the link and fill out the form to connect with us: https://bit.ly/3nU5j30 Would you like us to pray with you? Fill out the following form: https://bit.ly/3sYGRkQ Or call us on 086 100 1350. Would you like to join or start a Group? Let us know by filling in the following form: https://bit.ly/groups_ Partner financially with us: https://www.fathershousesa.org/giving/ Listen to our podcast: https://soundcloud.com/fathers-house-sa Connect with us on all our social media platforms @fathershousesa Visit our website at www.fathershousesa.org Download Church Centre Available on both App Store (iOS) and Google Play Store: http://onelink.to/d8qk5r

Cancellations will always happen — but there's a way to reduce and prevent them from happening! In this episode, Kirk Behrendt brings back Miranda Beeson, ACT's director of education, to break down cancellation and no-show percentage and what you can do if you have high levels of broken appointments. Stop making it too easy to cancel! To learn the secret to getting patients to show up, listen to Episode 919 of The Best Practices Show!Learn More About Miranda:Send Miranda an email: miranda@actdental.com Follow Miranda on ACT's Instagram: https://www.instagram.com/actdentalSend Courtney an email to learn more about ACT: courtney@actdental.com More Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 919: https://www.youtube.com/@actdental/videosRegister for ACT's To The Top Study Club (July 25, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-25-2025-ttt-study-club-tickets-1205497959849Main Takeaways:Your ideal cancellation/no-show percentage is under 10%.Proactively reach out to patients with unconfirmed appointments.Put a system in place for releasing or keeping unconfirmed appointments.Have a reminder system that utilizes both automated and personal outreach.Be intentional with your language. Don't call to confirm appointments — remind them.Communicate the value of appointments to patients and policies around missed visits.Snippets:0:00 Introduction.3:15 Cancellation and no-show percentage, explained.5:16 How this percentage impacts the practice.7:59 What it looks like when it's going well.9:47 What it looks like when it's not going...

Ms. Kim Woofter and Dr. John Cox discuss the latest updates to the evidence-based standards on oncology medical homes developed by ASCO and COA. These standards serve as the basis for the ASCO Certified program. They share the new and revised standards around topics including the culture of safety and just culture in oncology practice, geriatric assessment and geriatric assessment-guided management, and multidisciplinary team management. They expand on the importance of these standards for clinicians and oncology practices to ensure every patient receives optimal care. Read the complete standards, “Oncology Medical Homes: ASCO-Community Oncology Alliance Standards Update” at www.asco.org/standards. TRANSCRIPT These standards, clinical tools, and resources are available at www.asco.org/standards. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the JCO Oncology Practice, https://ascopubs.org/doi/10.1200/OP-25-00498 Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts. My name is Brittany Harvey, and today I'm interviewing Ms. Kim Woofter, a registered nurse in practice leadership and administration from AC3 Inc in South Bend, Indiana, and Dr. John Cox, a medical oncologist and adjunct faculty member from UT Southwestern Medical Center in Dallas, Texas, co-chairs on "Oncology Medical Homes, American Society of Clinical Oncology – Community Oncology Alliance Standards." Thank you for being here today, Ms. Woofter and Dr. Cox. Dr. John Cox: You bet. Ms. Kim Woofter: Thank you. Brittany Harvey: And then before we discuss these standards, I'd just like to note that ASCO takes great care in the development of its standards and ensuring that the ASCO Conflict of Interest Policy is followed for each guidance product. The disclosures of potential conflicts of interest for the expert panel, including Dr. Cox and Ms. Woofter, who have joined us here today, are available online with the publication of the standards in JCO Oncology Practice, which is linked in the show notes. So then, to dive into what we're here today to talk about, Dr. Cox, could you start us off by explaining what prompted an update to these ASCO-COA standards and what the scope of this update is? Dr. John Cox: Well, the ASCO-COA standards relative to defining and outlining Oncology Medical Home were initially published four or five years ago. At the time, we planned a regular update of the standards. So, in essence, this is a planned update. The whole program is built on the idea of continuous improvement. So, this update and future updates are prompted and defined by our literature, our science, the science of care delivery, and new developments and insights gained from studies and evaluations of care delivery methods, and informed by the practice. These standards are in place to underpin a program of care delivery by ASCO, the ASCO Certified, and as practices engage in this program, we are learning from them. The whole idea is to enlarge and improve how patients are cared for in practice. Brittany Harvey: Absolutely. It's great to have this iterative process to continue to review the evidence and update these standards that form the basis for ASCO Certified. So then, following that background, Ms. Woofter, I'd like to review the key points of the revised standards for our listeners. First, how do the revised standards address the culture of safety and just culture in oncology practice? Ms. Kim Woofter: I think safety is of utmost importance to all of us. So let me say that first and foremost. And what we know in oncology is our QOPI standards already address safety in the infusion suite process. So, safe delivery of chemotherapy agents and antineoplastics. It also talked about near misses and medication errors - absolutely essential, for sure. But what we need to do is look at a more systemic approach to safety because we know is processes throughout an organization they'll often cause you trouble. To do that, we know you need what we call a just culture, which is a very common term in today's workplace. But what it really means is it's a culture of open reporting of any potential for error, any potential for malfunction, and it can be in any place in the organization. So, what we are doing in our new standard is to say, look at your entire processes throughout the organization, and approach that in an open-minded way so that people don't feel scared to report things, and it's a really positive approach to intervening early and making sure that errors don't occur anywhere in the workplace. Brittany Harvey: Taking that systemic approach to look at overarching processes seems really key to ensuring safety in oncology practices. So then, the next new section, Dr. Cox, what are the new OMH standards surrounding geriatric assessment and geriatric assessment–guided management? Dr. John Cox: This is a challenging update for our standards. As many folks in practice recognize, there is a deep literature on recognizing the geriatric population in oncology. Geriatric - those in my age group over age 60, 65 - make up the majority of cancer patients in this country. And yet, there are many aspects that should be taken into account as you address treatment decisions in this population. ASCO's recognized this. There has been a guideline previously on geriatric assessment. It's been updated, and we really felt it's time that it be incorporated in any iteration of what oncology care delivery means, so, within the oncology medical home standards. In short, what the standard outlines is that practices that are using these standards, that are using this benchmark, should have a geriatric assessment for patients within the practice care and use that information to guide management. Now, the standard allows wide exploration of how practices meet this standard, but it really puts on the table that if an oncology practice in the United States, or anywhere in the world really, is adhering to a good practice, that they're going to include and recognize these assessments in practice. Ms. Kim Woofter: I would like to add that this is a highly discussed and reviewed standard. Many of our community practices were concerned that they would have the time and manpower to perform this assessment. We all know it reduces toxicities if done appropriately at treatment planning, and so the outcomes are better. And we really left it to the practices to define how they're going to implement it, understanding that it will evolve to every single patient, but maybe day one, it was a step approach to be able to implement. So, I was really proud of the team that - the expert panel - that said, okay, let's step into this, but we do think it's essential. Brittany Harvey: Absolutely. It's important to recognize that practices may have limited resources and time, and implementing it in the way that makes sense for them allows this to be a standard that can be used in practice. And it's great to have this geriatric assessment guideline integrated into these standards to improve care delivery. And we can provide a link to that guideline in the show notes of this episode as well (Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update). So then, following that section of the standards, Ms. Woofter, how do the updated standards now address multidisciplinary team management? Ms. Kim Woofter: Well, we address multidisciplinary team management in a more comprehensive way in the updated standard. We always thought that that was a critical piece when doing treatment planning, and we kind of highlighted it in a bigger way, understanding that not everybody has the same resources available at the time of treatment planning. And again, this was a much-discussed standard, in that that multidisciplinary team approach doesn't necessarily have to be in a tumor board or a prospective analysis of every case. It is actually a conversation between specialists, between the surgeon and pathologist and the medical oncologist. And we are saying, do what works for you, but we know that that team approach, every specialty coming to the table at time of treatment planning, truly provides better outcomes for our patients. And so we kind of reiterated that, understanding that again, it doesn't have to be a formal tumor board, but it has to be a dialogue between specialties. And we highlighted that again in the new standard. Brittany Harvey: Open communication of all team members is really critical to providing optimal care. Dr. Cox, I'd like to ask you, in your view, how will these updated standards impact both clinicians and oncology practices? Dr. John Cox: Well, our whole goal with discussing a comprehensive care model for oncology practice is to have a benchmark, to have an iteration of what good oncology care delivery looks like. So, our hope is that practices, all practices, whether you're participating formally in ASCO Certified, the marquee quality program for ASCO, or if you are simply running a practice or a team within an academic environment or institutional environment, these standards are to apply across the board wherever oncology is practiced - that you can look at these standards as a benchmark and compare what you are doing in your practice and where are the gaps. So ideally, we drive improved care across the board. You know, one thing I've learned over the last couple of years as ASCO Certified is getting spun up and using and implementing these standards, is practices are remarkably innovative. We've learned a lot by seeing how pilot practices have met the standards, and that's gone into informing how we can improve care delivery for all of our practices and, importantly, for the team members who are delivering this care. The fourth rail of burnout and the like is inefficiency that occurs in practice. And when you know you've got a good, spun-up, effective team, less burnout, less stress for practice. I hope clinicians and oncology practices will use this to help drive improvements in their care and gain insight into how they can approach practice problems in a better way. Kim, you've been leading practices. I have to ask you, your thoughts in leaning into this question. Ms. Kim Woofter: I think very well said, I will say that first. And what I love about this is for practice leaders who are new to our ecosystem, if you will, they need a playbook. It's “Where do I begin?” And Dr. Cox said it very well, no one does everything perfectly day one, but it's a step-by-step self-assessment approach to say, “How do I get to this gold standard?” I really love the standards because they are very comprehensive, everything from treatment planning to end of life. So it's the spectrum of the care we deliver in the oncology setting. So as a leader and an administrator, it is the standard I want all of my departments to understand, adhere to, and engage, and be excited about. We now have a baseline approach, and what's even more important, these standards will evolve as our intelligence evolves, as literature evolves. It's a system that will always grow and change, and that's what we love about it. It's not a one-and-done. So, I'm very proud of the fact that it gives them a road map. Brittany Harvey: Yes, these evidence-based standards provide a critical foundation for practices in ASCO Certified, for those team members you mentioned, and for quality improvement beyond just those individuals and practices as well. So then finally, to wrap us up, Ms. Woofter, what do these revised standards mean for patients receiving cancer treatment? Ms. Kim Woofter: Well, I think that's the most exciting part, is we all do this for our patients and the best outcomes for our patients and the best treatment plans for our patients and their families. And these standards, that is their core, their absolute core. So what it's going to do for a patient is they can say, “Am I at a practice that implements ASCO standards?” And if that is a ‘yes', there's a confidence that, “I am in an evidence-based medicine thinking practice, I have a team around me, they will care for me not only at time of treatment planning but at the time of end of life, they will help me be part of that decision-making, and they will give me resources available to me in my community.” So, it is a true comprehensive approach. As a patient, I have that comfort, that it is bigger than just a great doctor. It is a great team. As a patient, that would be very important to me and important to my family. That being said, Kim Woofter would love every practice to be ASCO Certified. Understanding that that isn't feasible day one, just to know that the practice is implementing and engaging the standards is the great place to start. Every patient can't go to an ASCO Certified practice day one, but our dream would be that everyone would adhere to those standards, engage those standards, believe them, educate their staff on what they mean, so that patient outcomes and satisfaction will be optimized for everyone. The other piece to this that we all know is if you give evidence-based medicine, cost-effective, efficient care, it's better for the system as a whole. And I'm not saying that insurance is our driver - certainly patient outcomes are our driver - but the whole ecosystem of oncology benefits when you do the right thing. Dr. John Cox: It's hard to add anything to Kim's good statements, but I just highlight that this whole area began with the patient-centered medical home, and every time we've met, patients and how we deliver care to patients is top of mind. I think that reflects our community. It reflects oncology as a whole. I don't know any oncologist or practice that is focused on anything else as the prime goal. Brittany Harvey: That's what I was just going to say. The ultimate goal here is to provide patient-centered care across where every single patient is receiving treatment and at every stage of that treatment. So, I want to thank you both so much for your work to update these standards, to review the evidence, and discuss with the experts on the panel to come up with the solutions that will help drive quality improvement across care delivery. So, thank you for that, and thank you for your time today, Dr. Cox and Ms. Woofter. And finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the complete standards, go to www.asco.org/standards. You can also find many of our standards and interactive resources in the free ASCO Guidelines app, which is available on the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast, and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

Thank you for joining us! To stay connected with us visit us here, on SoundCloud and on: Website: https://www.mynpmc.com/ Facebook: https://www.facebook.com/mynpmc YouTube: https://www.youtube.com/channel/UCnOiemCev_mHyZNgU2QgwnA Download the NPMC app on the: Google Play Store: https://play.google.com/store/apps/details?id=com.echurchapps.newparis&hl=en_US Apple App Store: https://apps.apple.com/us/app/new-paris-missionary-church/id1228753320 Give Online: https://pushpay.com/g/newparismissionarychurch New Paris Missionary Church is located in New Paris, Indiana. We would love for you to join us in person or online on Sundays as we worship God together. Our service begins at 10:00 a.m. We hope to see you soon!

You might think you're great at multitasking — but you're really not! In this episode, Kirk Behrendt brings in Renae Graeff, one of ACT's amazing coaches, to share how to maximize your dental assistants' skills so you can fully utilize them to better your practice. Don't try to do it all! To learn how to empower your assistants so they become more capable, more fulfilled, and a better partner for patient care, listen to Episode 918 of The Best Practices Show!Learn More About Renae:Send Renae an email: renae@actdental.com Follow Renae on ACT's Instagram: https://www.instagram.com/actdentalSend Courtney an email to learn more about ACT: courtney@actdental.com More Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 918: https://www.youtube.com/@actdental/videosRegister for ACT's To The Top Study Club (July 18th, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-18-2025-ttt-study-club-tickets-1205460116659Register for ACT's To The Top Study Club (July 25, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-25-2025-ttt-study-club-tickets-1205497959849Register to ACT's BPA for their 3-3-3 Onboarding Tool: https://join.actdental.com/users/sign_in?post_login_redirect=https%3A%2F%2Fjoin.actdental.com%2Fc%2Fpractice-coaching-tools%2F3-3-3-onboarding-model#emailRegister to ACT's BPA for their...

Dr. Lyudmila Bazhenova is back on the podcast to discuss the latest update of the living guideline on therapy for stage IV NSCLC without driver alterations. She shares the studies the Expert Panel reviewed in the first- and second-line settings, including NIPPON, HARMONi-2, and DUBLIN-3. Although these studies do not impact the existing guideline recommendations, Dr. Bazhenova provides context and comments on ongoing trials that will influence the next iteration of the living guideline. Read the full living guideline update “Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2025.1” at www.asco.org/thoracic-cancer-guidelines TRANSCRIPT This guideline, clinical tools, and resources are available at www.asco.org/thoracic-cancer-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology, https://ascopubs.org/doi/10.1200/JCO-25-01062 Brittany Harvey: Hello, and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts. My name is Brittany Harvey, and today I'm interviewing Dr. Lyudmila Bazhenova from University of California San Diego Moores Cancer Center, co-chair on "Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2025.1." It's great to have you back on the show today, Dr Bazhenova. Dr. Lyudmila Bazhenova: It's my pleasure to be here. Brittany Harvey: And then before we discuss this guideline update, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Bazhenova, who has joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. So then to dive into the content here, Dr. Bazhenova, this living clinical practice guideline for systemic therapy for patients with stage IV non–small cell lung cancer without driver alterations is updated on an ongoing continuous basis. So what prompted this latest update to the recommendations? Dr. Lyudmila Bazhenova: Living ASCO guidelines are designed to keep pace with rapidly evolving evidence that impacts treatment of our patients with lung cancer. As a committee, we are tasked with regular review of the published literature and determine if the new data warrants changes to existing recommendations. So in this recently published update, we evaluated new trials related to treatment of patients with metastatic lung cancer without driver alterations. Brittany Harvey: Excellent. Thank you for that explanation of the process. So, you just mentioned that the panel reviewed new trials for this update. So, which particular updated evidence did the panel review on first-line treatment options for patients with good performance status across histology and PD-L1 expression status, and how did this impact the recommendations? Dr. Lyudmila Bazhenova: For the first-line treatment option for patients without driver alterations, two studies met our criteria for review. One was the NIPPON trial from Japan, the second was the HARMONi trial. None of those two trials resulted in change in our guidelines, but I think they are giving us some additional information that would be useful for the way we treat patients with non–small cell lung cancer without driver alterations. For example, if we take those patients, we currently have several treatment options as a first line. One is monotherapy immunotherapy. You can give pembrolizumab as an example, and that was based on the KEYNOTE-024 and KEYNOTE-042 trials. Then we have a platinum doublet plus immunotherapy, and there are several trials that did that pathway. And then we have also an option of giving our patients dual IO immunotherapy combination, such as CheckMate 9LA and POSEIDON. At this point, we do not have any randomized trials comparing those three treatment modalities head-to-head. And the NIPPON trial was interesting to us because it was the first trial to compare CheckMate 9LA regimen, which is again, dual immunotherapy plus chemo, versus KEYNOTE-189 or KEYNOTE-407, which is a chemotherapy plus immunotherapy. And as a result of the study, while chemotherapy plus ipilimumab-nivolumab led to numerically higher overall survival, the difference was not statistically significant. And what is concerning in that trial is that we saw a higher number of treatment-related death occurring in nivolumab and ipilimumab arm compared to the pembrolizumab-chemotherapy arm. As a matter of fact, the trial was terminated early because of the increased risk of death. If you look at the treatment-related death in CheckMate 9LA, the 9LA study reported the treatment-related death to be 2%, and then in the NIPPON trial, the treatment-related death was 7%. Why is that happening? It's really difficult to say. The study was done in Japan. Maybe there is some pharmacogenomic differences between global population and Japan population. But certainly the higher rate of adverse events needs to be taken into account. Another interesting thing about this trial is that it did not show any differences in a subset analysis for patients with squamous histology as well as PD-L1 negative tumor. So while this does not change our current guidelines and CheckMate 9LA treatment still remains an appropriate treatment option, it kind of raises the possibility that this combination could be associated with a higher toxicity. And we do have a randomized US-based trial that is ongoing, and we are hoping that eventually we will be able to answer that question after the trial will be completed. The second trial we reviewed is HARMONi-2. So HARMONi-2 was a randomized, double-blind study which is conducted primarily in China, looking at bispecific PD-L1 and VEGF antibody called ivonescimab. And that took patients who were PD-L1 positive, as defined as more than 1% expression, and patients were randomized to pembrolizumab versus bispecific ivonescimab. And the study was positive. It showed improvement in median progression-free survival of 11 months versus almost 6 months in bispecific versus pembrolizumab. There were, however, higher grade 3 events in the ivonescimab arm. At this point, we are not changing our recommendations because this trial was done in an ex-US population, and we are awaiting a similar trial ongoing in the United States before we change recommendations and decide if ivonescimab needs to be included in our guidelines. Brittany Harvey: This context is very helpful when clinicians think through the data behind these options. And it's important that the panel reviews this evidence, even if it doesn't prompt a change to the recommendations. And we'll await results of those trials that you mentioned to further inform this guideline. So then beyond those studies for first line, what updated evidence did the panel review for second-line and subsequent treatment options for patients with good performance status, and how did this impact the recommendations? Dr. Lyudmila Bazhenova: So for second line, only one trial met the criteria, and that was DUBLIN-3. DUBLIN-3 is a phase 3 single-blind randomized trial comparing docetaxel versus docetaxel plus plinabulin. And the study enrolled patients with second or third line. They have to have had platinum-based chemotherapy and progressed. Plinabulin is an interesting compound. It's a small molecule tubulin binder that prevents polymerization of tubulin and appears to impact dendritic cell maturation and T-cell activation. This study enrolled 559 patients, randomly assigned them to two groups. And one important information about this study is that was a study that was envisioned before immunotherapy became a standard mainstream treatment for first-line therapy. And only 20% of patients had prior PD-1 exposure. So therefore, the results of that study need to be taken into context of this population no longer existing in the United States because we use PD-L1 inhibitors in the first line. And we saw that interesting in the plinabulin arm had lower rates of neutropenia but higher rates of serious adverse events. And at this point, we are not changing our guidelines for mainly two reasons. Number one, low number of patients that received prior treatment with first-line immune checkpoint inhibitors, as well as a modest overall survival benefit of this trial. Brittany Harvey: Understood. I appreciate you describing that study as well and why that evidence didn't prompt a change to those particular recommendations. So then, what should clinicians know as they implement this living guideline, and how does this new evidence impact clinicians and patients? Dr. Lyudmila Bazhenova: At this point, none of the studies that we reviewed resulted in a change in guidelines. We are still waiting for more global results from some of the studies that I highlighted. It shows that there's still a lot of questions we need to be answering in those patients. And I'm hoping that with future clinical trials, we will be able to definitively maybe recommend one treatment over another. But at this point, all the treatments that I mentioned before remain appropriate for patients with stage IV non–small cell lung cancer without driver alterations. Brittany Harvey: Definitely. And then you just mentioned that there's still a lot of outstanding questions in this field. You've mentioned a couple different studies where we're awaiting evidence. Beyond those that you already mentioned, what is the panel examining for future updates to this living guideline? Dr. Lyudmila Bazhenova: Right now, our next task is to come up with a full guidelines update. ASCO have certain rules for the guidelines committee members. And so we are gearing for a full guideline update, which hopefully will be ready by the end of 2025. Brittany Harvey: Excellent. We'll look forward to that full update of the living guideline, and we'll still await results of these ongoing trials to further inform this living guideline. So I want to thank you so much for your work to rapidly and continuously update this living guideline, and thank you for the time today, Dr. Bazhenova. Dr. Lyudmila Bazhenova: My pleasure. Brittany Harvey: And finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/thoracic-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you've enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

Dr. Joshua Reuss joints that podcast to discuss the latest changes to the living guideline on stage IV NSCLC with driver alterations. He discusses the new evidence for NSCLC with EGFR mutations and NRG1 fusions and how this impacts the latest recommendations from the panel. He shares ongoing research that the panel will review in the future for further updates to this living guideline, and puts the updated recommendations into context for clinicians treating patients with stage IV NSCLC. Read the full living guideline update “Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1” at www.asco.org/thoracic-cancer-guidelines TRANSCRIPT This guideline, clinical tools, and resources are available at www.asco.org/thoracic-cancer-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology, https://ascopubs.org/doi/10.1200/JCO-25-01061 Brittany Harvey: Hello and welcome to the ASCO Guidelines Podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts. My name is Brittany Harvey, and today I'm interviewing Dr. Joshua Reuss from Georgetown University, co-chair on "Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1." It's great to have you here today, Dr. Reuss. Dr. Joshua Reuss: Thank you. Happy to be here. Brittany Harvey: And then before we discuss this guideline, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Reuss, who has joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. So to dive into what we're here today to talk about, Dr. Reuss, this living clinical practice guideline for systemic therapy for patients with stage IV non–small cell lung cancer with driver alterations is updated on an ongoing basis. So what prompted this latest update to the recommendations? Dr. Joshua Reuss: Yes, thank you. It's very important that we have living guidelines that are continuously updated. We obviously don't live in a static environment where things are non-changing, and we really need to apply the most up-to-date and current evidence to treat our patients with the most effective strategies, the most groundbreaking strategies. And so to have guidelines that can be disseminated, particularly these ASCO guidelines, to treating providers is incredibly important. So, with any of these updates, we review ongoing studies, published work, for the quality of evidence to see if it's something that warrants making adjustments to our guidelines or at least incorporating the information so that providers can review it and incorporate this into their own personal decision-making. So in this particular update, we reviewed evidence particularly pertaining to EGFR-mutated non–small cell lung cancer and non–small cell lung cancer harboring an NRG1 fusion. Brittany Harvey: Yes, certainly there's a lot of new evidence in the advanced non–small cell lung cancer field, and so we appreciate the panel's continuous review of this evidence. So then you just mentioned two separate areas where the panel reviewed new evidence. So starting with that first one, what updated evidence did the panel review on first-line treatment options for patients with EGFR alterations, and how did this impact the recommendations? Dr. Joshua Reuss: Yes, so advanced EGFR-mutated non–small cell lung cancer, at least with classical activating alterations - that is our exon 19 deletions and our exon 21 L858R mutations - is something that's really evolved rapidly in the last few years. You know, for many years, we basically, for the frontline treatment setting, were saying, "Okay, we have a targeted therapy, osimertinib. We're going to give that, and we're going to see what effect we can get out of that," with, you know, a median time of duration of treatment response averaging around 18 months, knowing that there are some that that's a lot longer and some that are a lot shorter. But recently, we've seen a lot of data emerging on combination strategies. The guideline has already been updated to incorporate two of these combinations: osimertinib with chemotherapy based off of the FLAURA2 trial, and then the combination of amivantamab with lazertinib based off of the MARIPOSA trial. And that was data on progression-free survival that was published and led to those particular recommendations. Now, more recently, we've seen data come out in smaller, randomized studies for other combinations. And more recently, we reviewed the RAMOSE study. So this was a phase II, open-label, randomized trial for patients with tyrosine kinase inhibitor–naive and really, treatment-naive advanced EGFR-mutated non–small cell lung cancer harboring one of these two classical EGFR alterations, randomized to either osimertinib alone or osimertinib with the combination of ramucirumab, which is an anti-VEGF agent. There's been a lot of data, preclinical and clinical, for the role of VEGF blockade, particularly in EGFR-mutated non–small cell lung cancer, so exploring the combination of this for synergy in the frontline setting really made a lot of sense. So again, this was a phase II trial that randomized patients prospectively to one of these two regimens. The population here is really what we typically see with EGFR-mutated non–small cell lung cancer, predominantly a younger population - median age on this study was 65 - predominantly female - 71% female - and predominantly nonsmokers. Now, what this study showed was that at a median follow-up of 16.6 months, the progression-free survival favored the combination arm with a median progression-free survival of 24.8 months with the combination of osimertinib plus ramucirumab versus 15.6 months for osimertinib alone, for a hazard ratio of benefit of 0.55. The landmark one- and two-year endpoints for progression-free survival also favored the combination arm, and response rates were relatively comparable between groups, with overall adverse events being more frequent in the combination group, specifically high blood pressure, proteinuria, and epistaxis, which are our common adverse events related to VEGF-blocking agents. So, it's good to see data in this space. Now, of note, though, this was a phase II study, so not a phase III level of evidence. In addition, when looking at the population, this was a randomized, multicenter study, but it was a US-only population. There was also some imbalance in the number of visits between arms, so the combination arm was seen more frequently than the arm that got osimertinib alone. Now, the imaging assessments were no different, but obviously this could lead to potential confounding, at least in timing of awareness of potential side effects and and things being brought to the attention of investigators. So very promising data here, but because, you know, of this being a phase II study, this actually led to no changes in the guideline at this time. Brittany Harvey: Understood. Yes, as you mentioned prior, it's important to understand the full body of evidence and to review the trials even when it doesn't impact the recommendations. Dr. Joshua Reuss: And I will say that, you know, there is an ongoing phase III study looking at a very similar combination. It's the phase III ECOG-ACRIN trial of the combination of osimertinib plus bevacizumab versus osimertinib alone in this specific population. So, you know, I think we will see phase III–level data for a combination of VEGF with osimertinib, but again, promising phase II data that did not lead to a change in the recommendation at this time. Brittany Harvey: Absolutely. We'll look forward to that ongoing trial to learn more about combination in this patient population. So then moving to that second patient population that you mentioned earlier where the panel reviewed evidence, what is the updated evidence and recommendation for patients with NRG1 fusions? Dr. Joshua Reuss: Yeah, so this was an exciting update that we made more recently with this unique iteration of the living guidelines. So, NRG1 fusions, this is perhaps a newer kid on the block in terms of driver alterations that has been known to be identified in non–small cell lung cancer among other solid tumors. It is very rare, occurring in less than 1% of solid tumors, but something that we know is a unique oncogenic pathway that can lead to oncogenesis and cancer development, including in non–small cell lung cancer. So up until now, unfortunately, there have not been targeted therapies that target this unique alteration. It's somewhat different than other driver alterations where there's a top-level signaling change in a protein. This is more of a ligand alteration that then alters, that then enables activation of more classical pathways, but again, through upregulation of a unique ligand. So a slightly different pathway but something that we know should be able to be targeted to promote patient survival for those with NRG1 fusions. So the therapy here is a therapy called zenocutuzumab. It's an IgG1 bispecific antibody against HER2 and HER3. So it prevents the downstream dimerization and signaling that occurs as a result of this NRG1 fusion and upregulation of the NRG1 signal. This was, as you can imagine with a rare alteration, a large phase II registrational study that examined this in advanced solid tumors containing the NRG1 fusion. This is the NRG1 registrational trial. And this study enrolled patients with advanced solid tumors who had progressed on prior therapy. Patients were treated with zenocutuzumab 750 milligrams IV every two weeks. Among 158 response-evaluable solid tumor patients, the response rate was 30%, median duration of response of 11.1 months, and a median progression-free survival of 6.8 months. Now, in those with non–small cell lung cancer, that made up 93 response-evaluable patients, very similar outcomes there: a response rate of 29%, median duration of response of 12.7 months, and a median progression-free survival of 6.8 months. This therapy did appear to be well tolerated. The most common higher-grade emergent side effects - grade 3 or higher - were anemia occurring in 5% and elevated liver numbers occurring in 3%. So this is a subsequent-line study, so this led to the updated recommendation that clinicians may offer zenocutuzumab in the subsequent-line setting for patients with advanced non–small cell lung cancer who harbor NRG1 fusions. So I think this does speak toward the incredible importance of next-generation sequencing and molecular testing for patients, particularly to include testing that looks at the RNA. These large fusions can sometimes be very challenging to detect on DNA sequencing platforms alone, so it's important to, if you have a high level of suspicion for an alteration like this, perhaps some of the mucinous adenocarcinomas where it's been challenging to find a driver alteration, and it's someone who is a never-smoker, really would want to include molecular testing that assesses the RNA level and not just the DNA. Brittany Harvey: Absolutely. It's important to have all the biomarkers available so that clinicians are able to use that to inform their decision-making. So then, given these changes in the guideline, what should clinicians know as they implement this latest living guideline update? And how do these changes impact patients? Dr. Joshua Reuss: Yeah, I think talking in reverse order of what we just discussed here, there is a new guideline update for NRG1 fusions. So I think making sure that that's being evaluated, that clinicians are testing for that and really looking for that result that should be incorporated in in most next-generation large sequencing assays to get that result, but it's very important that that is not overlooked now that we do have a therapy that's available in the subsequent-line setting, though it is important to note that patients with NRG1 fusions, at least the limited data that there is suggests that the efficacy to standard chemoimmunotherapy regimens is overall poor. So physicians unfortunately might be facing this question for second-line therapy in patients with NRG1 fusions sooner rather than later. For the former, for EGFR-altered non–small cell lung cancer and how do we incorporate VEGF-containing regimens into these patients? Our guideline top-level update did not change based off of review of this new study, but it's important for clinicians to know what other combinations may exist. You know, there are phase III studies looking at this combination in the frontline setting. And of course, there is data on other bispecific molecules that incorporate VEGF in the subsequent-line setting, particularly a combination that includes the VEGF/PD-1 bispecific antibody ivonescimab that's being studied in the HARMONi-A trial for patients with EGFR-mutated advanced non–small cell lung cancer, for which we hope to get some more definitive data in the coming months. Brittany Harvey: Definitely. And then you've just mentioned a few ongoing trials where we're looking for evidence to inform future updates. But thinking beyond that, into the future, what is the panel examining for future updates to this living guideline? Dr. Joshua Reuss: It's a very exciting time to be in the world of treating advanced non–small cell lung cancer, particularly patients with driver alterations, because there is so much evolving data that's changing our practice in real time, again highlighting the importance of these living guideline updates. I'd say there's many things that we're excited to see. You know, a lot of the combination regimens in EGFR-mutated non–small cell lung cancer for which there are approvals and current recommendations in our guideline, particularly osimertinib plus chemotherapy and amivantamab plus lazertinib - those are the two approved combination strategies in the front line - we are now seeing the emergence of overall survival data for those combinations. So obviously that is something that's going to be very important for the committee to review and incorporate into guideline updates. There are several new therapies coming down the road for other driver populations. We recently saw an approval for taletrectinib for ROS1 fusion–positive non–small cell lung cancer, so it's going to be important that the committee reviews the data and the publications regarding that therapy. And then there are other novel therapies that we're looking to see updated data on. There are multiple antibody-drug conjugates, which take the potent power of a chemotherapy molecule and attempt to make that targeted with an antibody targeting to a unique feature on the cancer cell. And there are several antibody-drug conjugates that are in development at various levels of promise in this space, particularly in EGFR-mutated non–small cell lung cancer, and I anticipate seeing some emerging data for that coming up in the near future as well. So really, lots to be excited in the space and lots for our committee to review to give guidance on so that these patients can really receive the top-level care wherever they are being treated in the country and throughout the world. Brittany Harvey: Yes, we'll await this new data to continue to provide optimal options for patients with stage IV non–small cell lung cancer with driver alterations. So, Dr. Reuss, I want to thank you so much for your work to rapidly and continuously update and review the evidence for this guideline and thank you for your time today. Dr. Joshua Reuss: Thank you so much. Brittany Harvey: And finally, thank you to all of our listeners for tuning in to the ASCO Guidelines Podcast. To read the full guideline, go to www.asco.org/thoracic-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available on the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

How you communicate will make or break your practice. In this episode, Kirk Behrendt brings back Miranda Beeson, ACT's director of education, to break down the DiSC framework to help you better understand yourself and your team so you can improve communication and harmony in your practice. To take the first step to optimize your leadership style, listen to Episode 917 of The Best Practices Show!Learn More About Miranda:Send Miranda an email: miranda@actdental.com Follow Miranda on ACT's Instagram: https://www.instagram.com/actdentalSend Courtney an email to learn more about ACT: courtney@actdental.com More Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 917: https://www.youtube.com/@actdental/videosRegister for ACT's To The Top Study Club (July 18th, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-18-2025-ttt-study-club-tickets-1205460116659Register for ACT's To The Top Study Club (July 25, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-25-2025-ttt-study-club-tickets-1205497959849Register for ACT's Guide to Engaging Your Team with Data: https://join.actdental.com/users/sign_in?post_login_redirect=https%3A%2F%2Fjoin.actdental.com%2Fc%2Fpractice-coaching-tools%2Fguide-to-engaging-your-team-with-data#emailMain...

The hype train finally pulls into Union Terminal this week. David Beckham brings his band to TQL Stadium for a midweek performance between FC Cincinnati and Inter Miami. However, as much as The Herons have dominated headlines and jersey sales, the Orange & Blue still stand (slightly) ahead of Miami, and a win over the hottest team in MLS can stave off the oncoming wave. As much as we'll try to not mention LM 10 (and make a drinking game about it), this week we invite Daniel from Arriba Bolso to talk about the Argentinian G.O.A.T. Can the team fully function if Messi (DRINK!) manages to have a bad game? Does Javier Mascherano have the defense to keep Cincinnati away from the scoreboard? How does Rodrigo de Paul fit into this system, both physically and financially? Tune in and trade threads with us! #MLS #FCCincinnati #soccer Become a Patron! Subscribe to Cincinnati Soccer Talk Don't forget you can now download and subscribe to Cincinnati Soccer Talk on iTunes today! The podcast can also be found on Stitcher Smart Radio now. We're also available in the Google Play Store and NOW ON SPOTIFY! As always we'd love your feedback about our podcast! You can email the show at feedback@cincinnatisoccertalk.com. We'd love for you to join us on our Facebook page as well! Like us at Facebook.com/CincinnatiSoccerTalk.

Thank you for joining us! To stay connected with us visit us here, on SoundCloud and on: Website: https://www.mynpmc.com/ Facebook: https://www.facebook.com/mynpmc YouTube: https://www.youtube.com/channel/UCnOiemCev_mHyZNgU2QgwnA Download the NPMC app on the: Google Play Store: https://play.google.com/store/apps/details?id=com.echurchapps.newparis&hl=en_US Apple App Store: https://apps.apple.com/us/app/new-paris-missionary-church/id1228753320 Give Online: https://pushpay.com/g/newparismissionarychurch New Paris Missionary Church is located in New Paris, Indiana. We would love for you to join us in person or online on Sundays as we worship God together. Our service begins at 10:00 a.m. We hope to see you soon!

KB & Intern Jacob are BACK and kick things off with a bow on the Phillies first half of the season as they close out the weekend with a win over the Padres. Then they discuss a LOT of trade rumors and the new DEMON that the Phillies drafted in the first round of the 2025 MLB Draft. Then they also discuss Uno coming to Vegas casinos... or NOT?! Then KB rants about Love Island being a terrible TV product and Jacob wants to buy an NBA Jam machine for his dorm room. Then KB closes things out talking about wins for the Philadelphia Union and Waterdogs! SIGN UP FOR THE JAMIL DEMBY YOUTH FOOTBALL CAMP! linktr.ee/jamil.demby Onboarding Form: forms.gle/mZYnkiQcGv1ZxBSg9 Voicemail Line: speakpipe.com/UndergroundSportsPhiladelphia Support Our Sponsors! The City of Vineland: Visit www.vinelandcity.org/ and stay connected with the community and learn about important announcements, programs, and services offered by the city! Vineland, New Jersey... Where It's Always Growing Season! Rita's Italian Ice & Custard of Sewell, NJ: Visit Rita's in Sewell, NJ at 288 Egg Harbor Road and enjoy the best italian ice, cream ice, custard, and more all season long! Ice-Custard-Happiness '47 Brand Shop for your favorite sports fan and get FREE SHIPPING on ALL orders with '47 Brand! 47.sjv.io/e1Nyor Kenwood Beer Visit kenwoodbeer.com/#finder and see who has Kenwood Beer on tap in YOUR area and crack open an ice cold Kenwood Beer to celebrate Victory Monday and the holiday season! (MUST be 21+ to do so and PLEASE drink responsibly.) Merch & Apparel: www.phiapparel.co/shop + Use Code "UNDERGROUND" for 10% off! PLL App Download the PLL App in the App Store of Google Play Store and enter code OTBPOD in the Redeem Code section for 500XP on your account! Biñho Get 10% off your next purchase with code BINHOBENNETT62 from our pals at Biñho! binhoboard.com?bg_ref=pDJkDdNO1y Follow Us! Twitter: twitter.com/UndergroundPHI Instagram: www.instagram.com/undergroundphi/ TikTok: tiktok.com/@undergroundphi KB: twitter.com/KBizzl311 Watch LIVE: YouTube: www.youtube.com/@UndergroundSportsPhiladelphia FB: facebook.com/UndergroundSportsPHI Twitch: twitch.tv/UndergroundsportsPHI Intro Music: Arkells "People's Champ" Outro Music: Arkells "People's Champ" #fyp #Phillies #RingTheBell #GageWood #NBAJam #DOOP #Waterdogs #LoveIsland #Uno #download #review #subscribe

Cancellations and no-shows will always happen. But how well are you filling those gaps? In this episode of Metric Mondays, Kirk Behrendt brings back Miranda Beeson, ACT's director of education, to break down capacity percentage. They share the keys to maintaining a productive and efficient schedule even when your patients fall out. Don't settle for 84%! To learn how to proactively fill your schedule, listen to Episode 916 of The Best Practices Show!Learn More About Miranda:Send Miranda an email: miranda@actdental.com Follow Miranda on ACT's Instagram: https://www.instagram.com/actdentalSend Courtney an email to learn more about ACT: courtney@actdental.com More Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 916: https://www.youtube.com/@actdental/videosRegister for ACT's To The Top Study Club (July 18th, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-18-2025-ttt-study-club-tickets-1205460116659Register for ACT's To The Top Study Club (July 25, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-25-2025-ttt-study-club-tickets-1205497959849Main Takeaways:Your capacity percentage benchmark is 94% or higher.Pre-schedule your patients' next appointments before they leave.Utilize ideal day or block scheduling. Protect your high-value time blocks.Have someone own and review your schedule two days to two weeks in advance.When you have cancellations and no-shows, quickly fill those gaps using priority lists.Utilize...

We all have favorite snacks, drinks, and fast food treats that we love. However, every so often, those treats get discontinued for some reason or other. As a fond remembrance of foods past, Geek Salad is bringing you episode 257: The FDA's Secret Restricted Warehouse of Lost Foods. Join Andy, Mike, Joe, and Katherine (as well as the participators in their live stream) as they go over some of their favorite tasty treats of ages past. From Wendy's baked potato bar to Jolt Cola, they go over some of the items which satisfied their taste buds but have since been consigned to that big walk-in freezer in the sky. Did they unearth some fond memories for you? Geek Salad is available at www.geeksalad.podbean.com, or can be subscribed to at the iTunes store by using keyword “geek salad.”  Geek Salad is also available on Spotify,iTunes,  iHeart Radio and wherever else you get your podcasts! Also, check out the Podbean App where you can stream and download the entire Geek Salad archive right from your Android or iPhone!  You can get the app at either the Google Play Store or the Apple App Store!  Want Geek Salad swag?  Check out our new store on Tee Public, where you can get t-shirts, mugs, stickers, and so much other stuff!!!  Shop here! Geek Salad episodes are now also available to stream on YouTube.  “Like” and Subscribe to their channel at Geek Salad Podcast at www.youtube.com Contact Geek Salad at geeksaladradio@gmail.com.  Geek Salad is also available on Facebook under the group heading “Geek Salad Podcast.” Check out their website at www.geek-salad.com, and please subscribe to their Twitter/X, Threads, and Blue Sky feeds: @geeksaladradio Geek Salad is intended for adult listeners and contains coarse language and profanity.  Listener discretion is advised.

It comes home only once a year—twice if we're lucky—and each time, the "Hell Is Real" derby fails to disappoint. Ohio's biggest soccer rivalry returns to the confines of TQL Stadium Saturday evening. When FC Cincinnati and Columbus Crew clash for possession of the soul of Ohio, pride is on the line. However, the perspective of the radio booth may paint a different picture—how does the voice of The Crew see this rivalry? We spend some time with Chris Doran, the play-by-play broadcaster for Columbus Crew on 105.7 FM, to talk about the evolution of the Crew and "Hell Is Real". What was once a team that shied away from investment in Columbus soccer has become a squad that prioritizes success in the face of their younger brother. How does Chris see Saturday's crucial matchup pan out, and what do the Crew need to do to escape the Queen City with three points? Tune in and trade threads with us! #MLS #FCCincinnati #soccer Become a Patron! Subscribe to Cincinnati Soccer Talk Don't forget you can now download and subscribe to Cincinnati Soccer Talk on iTunes today! The podcast can also be found on Stitcher Smart Radio now. We're also available in the Google Play Store and NOW ON SPOTIFY! As always we'd love your feedback about our podcast! You can email the show at feedback@cincinnatisoccertalk.com. We'd love for you to join us on our Facebook page as well! Like us at Facebook.com/CincinnatiSoccerTalk.

You love your spouse or partner. But is working with them a good idea? In this episode of the Best Practices Show, Kirk Behrendt brings back Dr. Charlie Ward, visiting faculty member at The Pankey Institute, along with his wife and fellow dentist, Dr. Melody Ward, to share the benefits and challenges of working together and their secrets for making it work. To learn how they've done it for over a decade, listen to Episode 915 of The Best Practices Show!Learn More About Dr. Charlie Ward & Dr. Melody Ward:Send Dr. Charlie Ward an email: charlie@bmoredentalarts.com Follow Dr. Charlie Ward on Instagram: https://www.instagram.com/drcwardddsWatch Dr. Charlie Ward's webinars: https://restorativenation.comFollow Dr. Melody Ward on Instagram: https://www.instagram.com/mwardperioLearn more about their practice: https://www.baltimoredentalarts.comMore Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 915: https://www.youtube.com/@actdental/videosMain Takeaways:Have the conversation about why you want to work together and your goals in doing so.Learn about each other's personalities to improve understanding and communication.Make the time to get away from your practice and your family with your spouse.Be intentional about your time off. Going to CE doesn't count as vacation!Set clear rules and boundaries so you limit bringing work back home.Check in regularly with your spouse. Things are always changing.Snippets:0:00 Introduction.2:13 Dr. Charlie Ward's background.3:46 Dr. Melody Ward's background.5:04 How they make it...

Welcome to church! Join us for church every Sunday at 9AM and 5PM. --------------------------------------------------------- Are you new to Father's House Church? Follow the link and fill out the form to connect with us: https://bit.ly/3nU5j30 Would you like us to pray with you? Fill out the following form: https://bit.ly/3sYGRkQ Or call us on 086 100 1350. Would you like to join or start a Group? Let us know by filling in the following form: https://bit.ly/groups_ Partner financially with us: https://www.fathershousesa.org/giving/ Listen to our podcast: https://soundcloud.com/fathers-house-sa Connect with us on all our social media platforms @fathershousesa Visit our website at www.fathershousesa.org Download Church Centre Available on both App Store (iOS) and Google Play Store: http://onelink.to/d8qk5r

Welcome to church! Join us for church every Sunday at 9AM and 5PM. --------------------------------------------------------- Are you new to Father's House Church? Follow the link and fill out the form to connect with us: https://bit.ly/3nU5j30 Would you like us to pray with you? Fill out the following form: https://bit.ly/3sYGRkQ Or call us on 086 100 1350. Would you like to join or start a Group? Let us know by filling in the following form: https://bit.ly/groups_ Partner financially with us: https://www.fathershousesa.org/giving/ Listen to our podcast: https://soundcloud.com/fathers-house-sa Connect with us on all our social media platforms @fathershousesa Visit our website at www.fathershousesa.org Download Church Centre Available on both App Store (iOS) and Google Play Store: http://onelink.to/d8qk5r

Thank you for joining us! To stay connected with us visit us here, on SoundCloud and on: Website: https://www.mynpmc.com/ Facebook: https://www.facebook.com/mynpmc YouTube: https://www.youtube.com/channel/UCnOiemCev_mHyZNgU2QgwnA Download the NPMC app on the: Google Play Store: https://play.google.com/store/apps/details?id=com.echurchapps.newparis&hl=en_US Apple App Store: https://apps.apple.com/us/app/new-paris-missionary-church/id1228753320 Give Online: https://pushpay.com/g/newparismissionarychurch New Paris Missionary Church is located in New Paris, Indiana. We would love for you to join us in person or online on Sundays as we worship God together. Our service begins at 10:00 a.m. We hope to see you soon!

The Boox Palma 2, a compact e-reader with a 6.13-inch ePaper display and Android 13, is available at a discounted price for Prime Day. The device features access to the Google Play Store, 128GB of storage, Bluetooth support, a fingerprint reader, and an eight-day battery life. It supports multiple file formats, including PDF, EPUB, MOBI, and DOC, and allows users to download productivity and reading apps. The Prime Day deal is available through Amazon and Boox for a limited time.Learn more on this news by visiting us at: https://greyjournal.net/news/ Hosted on Acast. See acast.com/privacy for more information.

Every other week I'm republishing one of my most popular or impactful episodes and adding an update, new insight, or context that will help you benefit from it even more. This week I'm highlighting Episode #69, which is all about imposter syndrome. I've talked about imposter syndrome time and time again to different groups of nursing students and that's because almost every single person can relate. If you've ever said to yourself, "I don't belong here" or "They're going to find out I don't know what I'm talking about" then you may very well suffer from imposter syndrome. In this podcast episode, Nurse Mo talks about imposter syndrome, why it's so common in nursing students and why it has absolutely nothing to do with how amazing you actually are. ___________________ ⁠Full Transcript⁠ - Read the article and view references ⁠FREE CLASS⁠ - If all you've heard are nursing school horror stories, then you need this class! Join me in this on-demand session where I dispel all those nursing school myths and show you that YES...you can thrive in nursing school without it taking over your life! ⁠Crucial Concepts Bootcamp⁠ - Start nursing school ahead of the game, or reset after a difficult first semester with my nursing school prep course, Crucial Concepts Bootcamp. Learn key foundation concepts, organization and time management, dosage calculations, and so much more. ⁠20 Secrets of Successful Nursing Students⁠ – Learn key strategies that will help you be a successful nursing student with this FREE guide! ⁠Study Sesh⁠ - Change the way you study with this private podcast that includes dynamic audio formats that help you review and test your recall of important nursing concepts on-the-go. Free yourself from your desk with Study Sesh! ⁠Straight A Nursing App⁠ - Study on-the-go with the Straight A Nursing app! Review more than 5,000 flashcards covering a wide range of subjects including Fundamentals, Pediatrics, Med Surg, Mental Health, Maternal Newborn, and more! Available for free in the Apple App Store and Google Play Store.

KB, Harrison, & Intern Jacob are BACK and the boys are THRILLED that the Phillies annual trip to a living Hell on Earth, aka San Francisco, is OVER! The guys recap the hellscape of a series, Bryce Harper finally looking like himself, and prep for the Padres. They also talk some more trade rumors, Underground Stats & Info, and All-Star snubs. Then Jamil Demby sits down with KB ahead of his annual youth football camp to talk life, football stories, and more. Then the fellas talk Summer League, the WNBA coming to Philly, the Union getting stormed out of the Open Cup match against New York, and the Waterdogs kicking off the second half of their season! SIGN UP FOR THE JAMIL DEMBY YOUTH FOOTBALL CAMP! https://linktr.ee/jamil.demby Onboarding Form: forms.gle/mZYnkiQcGv1ZxBSg9 Voicemail Line: speakpipe.com/UndergroundSportsPhiladelphia Support Our Sponsors! The City of Vineland: Visit www.vinelandcity.org/ and stay connected with the community and learn about important announcements, programs, and services offered by the city! Vineland, New Jersey... Where It's Always Growing Season! Rita's Italian Ice & Custard of Sewell, NJ: Visit Rita's in Sewell, NJ at 288 Egg Harbor Road and enjoy the best italian ice, cream ice, custard, and more all season long! Ice-Custard-Happiness '47 Brand Shop for your favorite sports fan and get FREE SHIPPING on ALL orders with '47 Brand! 47.sjv.io/e1Nyor Kenwood Beer Visit kenwoodbeer.com/#finder and see who has Kenwood Beer on tap in YOUR area and crack open an ice cold Kenwood Beer to celebrate Victory Monday and the holiday season! (MUST be 21+ to do so and PLEASE drink responsibly.) Merch & Apparel: www.phiapparel.co/shop + Use Code "UNDERGROUND" for 10% off! PLL App Download the PLL App in the App Store of Google Play Store and enter code OTBPOD in the Redeem Code section for 500XP on your account! Biñho Get 10% off your next purchase with code BINHOBENNETT62 from our pals at Biñho! https://binhoboard.com?bg_ref=pDJkDdNO1y Follow Us! Twitter: twitter.com/UndergroundPHI Instagram: www.instagram.com/undergroundphi/ TikTok: tiktok.com/@undergroundphi KB: twitter.com/KBizzl311 Watch LIVE: YouTube: www.youtube.com/@UndergroundSportsPhiladelphia FB: facebook.com/UndergroundSportsPHI Twitch: twitch.tv/UndergroundsportsPHI Intro Music: Arkells "People's Champ" Outro Music: Arkells "People's Champ" #fyp #Phillies #RingTheBell #BryceHarper #JamilDemby #Guest #Interview #download #review #subscribe

This week, Marianna sits down with John Faragon for Part 2 of out two-part series covering all things CROI 2025. CROI is the Conference on Retroviruses and Opportunistic Infections. Learn all about the latest in PrEP, the BEe-HIVe study, and more.  -- Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=PCS6722)--Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes. --Check out our free online courses: www.necaaetc.org/rise-courses--Download our HIV mobile apps:Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=USApple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

When leadership isn't aligned, it will lead to chaos. So, how do you prevent conflict and the day-to-day struggles? In this episode of Practical Solutions Day, Kirk Behrendt brings back Carlie Einarson, one of ACT's amazing coaches, with three keys to alignment and healthy partnerships. Misalignment is the root of all evil! To learn how to get in sync to gain trust and boost productivity, listen to Episode 914 of The Best Practices Show!Learn More About Carlie:Send Carlie an email: carlie@actdental.com Follow Carlie on ACT's Instagram: https://www.instagram.com/actdentalSend Courtney an email to learn more about ACT: courtney@actdental.com More Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 914: https://www.youtube.com/@actdental/videosJoin ACT's BPA for the Strategic Vision Creator tool: https://join.actdental.com/users/sign_in?post_login_redirect=https%3A%2F%2Fjoin.actdental.com%2Fc%2Fpractice-coaching-tools%2Fstrategic-vision-creator-tool#emailRegister for ACT's To The Top Study Club (July 18th, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-18-2025-ttt-study-club-tickets-1205460116659Register for ACT's To The Top Study Club (July 25, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-25-2025-ttt-study-club-tickets-1205497959849Main...

PlayDayz, a new app designed to help parents connect, arrange playdates, and share childcare within their trusted networks, has launched in Ireland. Developed in partnership with award-winning Irish software firm Square Root Solutions, PlayDayz aims to make playdates and childcare more accessible, affordable, and community-driven. PlayDayz app launches in Ireland Flexible, affordable membership PlayDayz is available exclusively in the Republic of Ireland at launch, with plans to expand soon. All new households receive a 30-day free trial, and membership is flexible with no contracts: Standard (€0.99/month): Parent-child meetups and private playdate childcare. Premium (€1.99/month): Includes all standard features plus a day-care share for school holidays. How PlayDayz works 1. Parent and child meetups Parents can connect with others nearby for one-on-one or group playdates. Whether it's a coffee catch-up or a full day out, PlayDayz makes it easy to coordinate meetups. Parents can also add au pairs or childminders to their profile. 2. Free playdate childcare Parents build a private network of trusted friends, family, or school parents. When they need short-term childcare - like for a gym session or appointment - they send a request. The app's turn-based system ensures fairness, making free, reliable childcare accessible without awkwardness. 3. Day-care share for school holidays (Premium members only) School holidays can be difficult to manage for working parents. PlayDayz helps parents coordinate shared childcare, matching them with others in their area with similar needs. A schedule is generated two weeks in advance, ensuring fair, cost-free childcare and social opportunities for children. Safety and privacy first New users must provide government-issued ID, verified by PlayDayz admins. Personal details are never shared, and all communication is handled via secure in-app messaging. A community-driven solution PlayDayz founder and busy mother, Mia Shepherd, was inspired by her own childcare challenges. "For years, I saw how difficult school holidays were for working parents… Reliable childcare in Ireland is expensive and limited. PlayDayz makes it easy for parents to share responsibilities, while also giving children more opportunities to play and socialise." Mia wanted to create a community-driven solution for short-term childcare while also addressing parents' growing need for social connections. "Since becoming a mother myself, I've often needed childcare for just a couple of hours… but hiring a childcarer for short stints is unrealistic and expensive. With PlayDayz, parents can take turns within their trusted network - so it's free, fair, and easy for everyone. "More recently, I noticed on social media a real desire for parents to meet with others nearby, but no dedicated platform exists for this purpose. So I'm hoping it gives parents a better social life too!" Available NOW PlayDayz is available for download on the Apple App Store and Google Play Store. Parents in Ireland can join the PlayDayz community and enjoy a free 30-day trial. Follow them on Instagram; @playdayz_playdates Follow them on Facebook ; Playdayz (playdayz playdates) For more information, visit www.playdayzplaydates.com or contact info@playdayzplaydates.com See more breaking stories here.

Do you start every month with an empty schedule? Is your team scrambling to fill your chairs? There's a better way to keep your practice full! In this episode of Metric Mondays, Kirk Behrendt brings back Miranda Beeson, ACT's director of education, to break down pre-appointment percentage and the missed opportunities when you don't schedule your patients' next visits. To learn how to pre-appoint patients and keep them tethered to your practice, listen to Episode 913 of The Best Practices Show!Learn More About Miranda:Send Miranda an email: miranda@actdental.com Follow Miranda on ACT's Instagram: https://www.instagram.com/actdentalSend Courtney an email to learn more about ACT: courtney@actdental.com More Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 913: https://www.youtube.com/@actdental/videosRegister for ACT's To The Top Study Club (July 18th, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-18-2025-ttt-study-club-tickets-1205460116659Register for ACT's To The Top Study Club (July 25, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-25-2025-ttt-study-club-tickets-1205497959849Main Takeaways:Keep your pre-appointment percentage above 65% to reduce patient attrition.Set the expectation that every patient leaves with their next visit scheduled.Scheduling your patients' next appointment is the default. It's not optional!When patients cancel, reschedule the appointment in that moment.Tie patients' appointments to their...

SPECIAL INBOUND LOGISTICS VIDEO PODCAST SERIES: The 3PL space is a crowded and complex field where companies leverage whatever they can to stay competetive. Where some 3PLs focus on technology, others concentrate on service. But what can a company accomplish when they proffer a solution that considers the people providing the service as they work with the most innovative technologies to address client needs? Jim Ritchie, President and CEO of Redstone Logistics, speaks with Inbound Logistics Publisher, Keith Biondo and shares his insights into Redstone's approach to the 3PL market. See the full video here: https://www.inboundlogistics.com/video-podcasts/ FOR MORE INFORMATION: Redstone Logistics: https://redstonelogistics.com/ DO YOU WANT TO RESPOND TO THIS EPISODE? Call our Dialog Line: 888-878-3247 DOWNLOAD THE NEW INBOUND LOGISTICS APP featuring the updated and expanded Logistics Planner! Available on iTunes and the Google Play Store: bit.ly/ILMagApp  bit.ly/ILMagAppGoogle Are you a #logistics Thought Leader that would like to be featured on the Inbound Logistics Podcast?  Connect with me on Twitter:  @ILMagPodcast   Email me: podcast@inboundlogistics.com   Connect with Inbound Logistics Magazine on LinkedIn: https://www.linkedin.com/company/inbound-logistics Follow us on Twitter: www.twitter.com/ILMagazine Like us on Facebook: www.facebook.com/InboundLogistics Catch our latest videos on YouTube: www.youtube.com/inboundlogistics   Visit us at www.inboundlogistics.com

You became a dentist for the freedom it provides. But PPOs are putting a chokehold on that freedom! In this episode of Clinical Edge Fridays, Kirk Behrendt brings back Dr. Barrett Straub, ACT's CEO, to do a deep dive into how you can break free from PPOs for a better practice and better life. They share the tools you can use, what steps to take, and how to choose which PPOs to strategically drop first. If you're ready to reclaim your freedom, listen to Episode 912 of The Best Practices Show!Learn More About Dr. Straub:Send Dr. Straub an email: barrett@actdental.com Join Dr. Straub on Facebook: https://www.facebook.com/barrett.d.straubSend Gina an email to learn more about ACT: gina@actdental.com Send Courtney an email to learn more about ACT: courtney@actdental.com More Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 912: https://www.youtube.com/@actdental/videosRegister for ACT's To The Top Study Club (July 18th, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-18-2025-ttt-study-club-tickets-1205460116659Register for ACT's To The Top Study Club (July 25, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-25-2025-ttt-study-club-tickets-1205497959849Main Takeaways:You give patients treatment plans before doing dentistry. Do the same for your practice.It doesn't have to be all or none with PPOs. Determine what's the right mix for you.Understand

You're going to need FIRE for an explosive Fourth of July holiday, and we could be seeing that with the Chicago Fire coming to TQL Stadium. Last time against Chicago, FC Cincinnati escaped with another one-goal win on the road, but needed three goals to pull it off. Since then, Chicago has been the most potent offense in the East, but have only a +4 goal differential to show for it. What should we be aware of the second time with a half-season processed under head coach Gregg Berhalter? How has the likes of Philip Zinckernagel snuck his way onto the All-Star Game roster? We ask the host of the "Danny T Radio" YouTube channel if the Fire are a legitimate threat to the Eastern Conference this season. (While we're at it, let's look at our soccer kit collections.) Tune in and trade threads with us! #MLS #FCCincinnati #soccer Become a Patron! Subscribe to Cincinnati Soccer Talk Don't forget you can now download and subscribe to Cincinnati Soccer Talk on iTunes today! The podcast can also be found on Stitcher Smart Radio now. We're also available in the Google Play Store and NOW ON SPOTIFY! As always we'd love your feedback about our podcast! You can email the show at feedback@cincinnatisoccertalk.com. We'd love for you to join us on our Facebook page as well! Like us at Facebook.com/CincinnatiSoccerTalk.

CHP Genel Başkanı Özgür Özel hakkında dokunulmazlığının kaldırılması talebiyle fezleke hazırlandı. LeMan dergisine yönelik soruşturmada gözaltına alınanların tamamı tutuklandı.Bu bölüm Hillside City Club hakkında reklam içermektedir. Dinlediğiniz bu podcast bölümü, yaklaşık 7 dakika sürüyor. 7 dakika süren ve kendinize yatırım yapmanızı sağlayan bir aktivite daha isterseniz, sizi Hillside City Club'ın yeni uygulaması “Hillside 7 Minutes” ile tanıştıralım. “Hillside 7 Minutes”, 7 dakikalık egzersizlerle formunuzu korumanıza destek oluyor. “Hillside 7 Minutes ” uygulamasını Appstore'dan ya da Google Play Store'dan indirmek için burayı ziyaret edebilirsiniz. Learn more about your ad choices. Visit megaphone.fm/adchoices

Sometimes, you have a bad hire. But oftentimes, it's bad onboarding! In this episode of Practical Solutions Day, Kirk Behrendt brings back Adriana Booth, one of ACT's amazing coaches, to help you understand the importance of onboarding and how to do it right. To learn how to onboard — not waterboard — new team members, listen to Episode 911 of The Best Practices Show!Learn More About Adriana:Join Adriana on Facebook: https://www.facebook.com/adriana.boothFollow Adriana on Instagram: https://www.instagram.com/adrimariebSend Courtney an email to learn more about ACT: courtney@actdental.com More Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 911: https://www.youtube.com/@actdental/videosRegister for ACT's To The Top Study Club (July 18th, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-18-2025-ttt-study-club-tickets-1205460116659Register for ACT's To The Top Study Club (July 25, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-25-2025-ttt-study-club-tickets-1205497959849Become ACT's BPA Premium Member for the 3-3-3 Onboarding Tool: https://join.actdental.com/users/sign_in?post_login_redirect=https%3A%2F%2Fjoin.actdental.com%2Fc%2Fpractice-coaching-tools%2F3-3-3-onboarding-model#emailBecome ACT's BPA Premium Member for the Check-In Agenda:

Welcome to church! Join us for church every Sunday at 9AM and 5PM. --------------------------------------------------------- Are you new to Father's House Church? Follow the link and fill out the form to connect with us: https://bit.ly/3nU5j30 Would you like us to pray with you? Fill out the following form: https://bit.ly/3sYGRkQ Or call us on 086 100 1350. Would you like to join or start a Group? Let us know by filling in the following form: https://bit.ly/groups_ Partner financially with us: https://www.fathershousesa.org/giving/ Listen to our podcast: https://soundcloud.com/fathers-house-sa Connect with us on all our social media platforms @fathershousesa Visit our website at www.fathershousesa.org Download Church Centre Available on both App Store (iOS) and Google Play Store: http://onelink.to/d8qk5r

Welcome to church! Join us for church every Sunday at 9AM and 5PM. --------------------------------------------------------- Are you new to Father's House Church? Follow the link and fill out the form to connect with us: https://bit.ly/3nU5j30 Would you like us to pray with you? Fill out the following form: https://bit.ly/3sYGRkQ Or call us on 086 100 1350. Would you like to join or start a Group? Let us know by filling in the following form: https://bit.ly/groups_ Partner financially with us: https://www.fathershousesa.org/giving/ Listen to our podcast: https://soundcloud.com/fathers-house-sa Connect with us on all our social media platforms @fathershousesa Visit our website at www.fathershousesa.org Download Church Centre Available on both App Store (iOS) and Google Play Store: http://onelink.to/d8qk5r

Your patients might agree to full-case treatment. But how many schedule those appointments same-day? In this episode of Metric Mondays, Kirk Behrendt brings back Miranda Beeson, ACT's director of education, to break down treatment dollar amount acceptance percentage. By tracking this metric, you can see how much of your diagnosed care is turning into real dentistry. To learn how to get patients to accept and schedule higher value treatment, listen to Episode 910 of The Best Practices Show!Learn More About Miranda:Send Miranda an email: miranda@actdental.com Follow Miranda on ACT's Instagram: https://www.instagram.com/actdentalSend Courtney an email to learn more about ACT: courtney@actdental.com More Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 910: https://www.youtube.com/@actdental/videosRegister for ACT's To The Top Study Club (July 18th, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-18-2025-ttt-study-club-tickets-1205460116659Register for ACT's To The Top Study Club (July 25, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-25-2025-ttt-study-club-tickets-1205497959849Main Takeaways:Show patients the full picture. Let them decide how much they want to do, and when.For a full case, schedule as many appointments as possible, not just the first one.Present the value before the price. Use visuals to show potential outcomes.Help patients plan for the dentistry they will need in their retirement.If you have a consult...

It's time for the winged lions to take on the wingless variety. FC Cincinnati rides a mini-streak to take on Orlando City SC in the Magic Kingdom. This weekend's match could be the must-watch on Saturday, as both lurk atop the table. However, head coach Óscar Pareja has Orlando riding high behind a cohesive attack that boasts the most goals in the East. We talk with Nic from The Mane Land to get his thoughts on Orlando's life after Facundo Torres's departure, the instant rise of Alex Freeman to USMNT starter, and how defensively stout both teams could be this weekend. (Perhaps we also get an early weather report with all that humidity down there.) Tune in and trade threads with us! #MLS #FCCincinnati #soccer Become a Patron! Subscribe to Cincinnati Soccer Talk Don't forget you can now download and subscribe to Cincinnati Soccer Talk on iTunes today! The podcast can also be found on Stitcher Smart Radio now. We're also available in the Google Play Store and NOW ON SPOTIFY! As always we'd love your feedback about our podcast! You can email the show at feedback@cincinnatisoccertalk.com. We'd love for you to join us on our Facebook page as well! Like us at Facebook.com/CincinnatiSoccerTalk.

Canada and the United States may not face each other yet in Gold Cup competition, but the North and Great White North will still face each other. FC Cincinnati tries to make it a winning streak against CF Montréal this Wednesday evening. The last time the Orange & Blue traveled to Stade Saputo, they came back with a 2-1 loss, but some distant Orellano magic quelled any thoughts of an away win later on. The first half of the season has been a struggle for Le CFM, but some hope still exists. We talk with Justine from the 1642 MTL supporters' group to get her thoughts on the "buy low, sell high" strategy and the coaching change early in the season. How can Montréal make an impact against a Cincinnati squad looking for momentum? Tune in and trade threads with us! #MLS #FCCincinnati #soccer Become a Patron! Subscribe to Cincinnati Soccer Talk Don't forget you can now download and subscribe to Cincinnati Soccer Talk on iTunes today! The podcast can also be found on Stitcher Smart Radio now. We're also available in the Google Play Store and NOW ON SPOTIFY! As always we'd love your feedback about our podcast! You can email the show at feedback@cincinnatisoccertalk.com. We'd love for you to join us on our Facebook page as well! Like us at Facebook.com/CincinnatiSoccerTalk.